Skip to main content

NASDAQ:CRDF Stock Forecast, Price Targets (Buy or Sell) | CRDF Cardiff Oncology Analyst Ratings

While we only include contractual acquisitions when calculating A/B and A-B, when evaluating qualitative factors, we focus more on a company's track record and our expectation for financial management. In this respect, the quantitative and qualitative factors under the liquidity criteria are meant to complement each other and produce a more comprehensive view of a company's future liquidity position.

We estimate CRDF Cardiff Oncology stock forecast parameters by: On Balance Volume (OBV) with Sign Test

CRDF Cardiff Oncology Stock Forecast (Buy or Sell) as of 21 Apr 2022 for (n+30)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with On Balance Volume (OBV) and Sign Test. Machine Learning based stock forecast (n+30) for CRDF Cardiff Oncology as below:

Time series to forecast n: 21 Apr 2022 for (n+30)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %

 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |